sudden onset of exhaustion or lethargy at higher doses Nausea Fatigue Pain, swelling, or tenderness associated with injection only Dizziness associated with injection only The relationship between DSIP and alcohol consumption has been explored in limited research, with researchers finding lower DSIP content associated with alcoholization in rats [21]
Property Detail Full Name Body Protection Compound 157 Amino Acids 15 (pentadecapeptide) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1,419 g/mol Forms reviewed by FDA Free base and acetate salt FDA Status Not approved Active IND applications None (as of April 2026) Compounding status Under reclassification review (July 23-24, 2026) Is BPC-157 FDA Approved in 2026
On the other hand, if you are self-administering, then the thigh is a more convenient location
For advanced osteoarthritis involving the entire joint, supplement local injections with a systemic abdominal injection (split the daily dose)
Q3: How many syringe units is 300 mcg of AOD-9604